About purposeful: Computational Drug Repurposing
computational drug repurposing, computational drug repositioning, machine learning, artificial intelligence, data mining, pharmaceutical manufacturing, pharmaceuticals, pths drug development, big data, research and development in the physical, engineering, and life sciences, therapeutic candidates, pharmacometric modeling, orphan drug designation, b2b, big data analytics, disease phenotypes, dermatology indications, regulatory compliance
purposeful: Computational Drug Repurposing's Tech Stack
Frontend
Backend
Analytics
Marketing
Cloud
Decision Makers at purposeful: Computational Drug Repurposing
2 contactsCharalampos Chomenidis
Co-Founder / CTO
Georgios Drakakis
Chief Executive Officer
Unlock full contact details including verified emails and LinkedIn profiles
Upgrade to ProSales Outreach Angle
WordPress as a CMS signals a content-driven or SMB digital presence. SEO tools, hosting solutions, and page-builder plugins are natural fits for outreach.
purposeful: Computational Drug Repurposing's Position in the StackWho Database
- • purposeful: Computational Drug Repurposing is 1 of 2,188 pharmaceuticals companies tracked in StackWho.
- • 2,175 pharmaceuticals companies in our database have verified decision-maker emails (99% of the cohort).
- • 1,037 companies in Attica are in the StackWho database.
- • 700 pharmaceuticals companies are in the 1-10 employee range (same size as purposeful: Computational Drug Repurposing).
Technology detection from public web signals. Decision-maker contacts compiled from LinkedIn public profiles, company filings, and verified outbound testing. Methodology & sources · Updated July 2026.
Frequently Asked Questions
What technology does purposeful: Computational Drug Repurposing use?
purposeful: Computational Drug Repurposing uses Cloudflare DNS, Gmail, Google Apps, CloudFlare Hosting, WordPress.org, Mobile Friendly, and 7 more technologies. This data is sourced from StackWho's technology detection engine.
How do I contact the decision makers at purposeful: Computational Drug Repurposing?
StackWho has verified email addresses for 2 decision makers at purposeful: Computational Drug Repurposing. Pro members can access direct emails for the CEO, CTO, VP of Engineering, and other key contacts. Use StackWho to reach purposeful: Computational Drug Repurposing directly for sales, recruiting, or partnerships.
What industry is purposeful: Computational Drug Repurposing in?
purposeful: Computational Drug Repurposing operates in the pharmaceuticals industry, headquartered in Athens, Attica, Greece. StackWho tracks technology stacks and decision maker contacts for companies across all industries.
Can I export purposeful: Computational Drug Repurposing's contact data?
Yes. StackWho Pro members can export decision maker contact data for purposeful: Computational Drug Repurposing and similar companies to CSV. Use the export feature to build targeted prospect lists segmented by technology stack, industry, or location.
Similar pharmaceuticals Companies
View allAstraZeneca
astrazeneca.com
Sanofi
sanofi.com
Pfizer
pfizer.com
Novo Nordisk
novonordisk.com
Decision Makers
Charalampos Chomenidis
Co-Founder / CTO
Georgios Drakakis
Chief Executive Officer
More in pharmaceuticals
View all companiesCompanies in Attica
Browse AtticaTechnologies Used
-
Cloudflare DNS
- Gmail
- Google Apps
-
CloudFlare Hosting
-
WordPress.org
- Mobile Friendly
-
Nginx
-
Google Tag Manager
- +5 more in full profile